The efficacy and safety of TachoSil as haemostatic treatment in robot assisted radical prostatectomy
Not Applicable
Recruiting
- Conditions
- Prostatic cancer
- Registration Number
- JPRN-UMIN000015473
- Lead Sponsor
- Division of Urology, Department of Surgery, Tottori University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method laboratory data(Hgb,WBC,Plt,CRP,PT,APTT)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Comparative efficacy TachoSil versus other topical haemostatic agents robot-assisted radical prostatectomy
Adverse events associated with TachoSil use in urological surgery adhesion immunogenicity
Impact of haemostatic techniques on nerve sparing during robot-assisted radical prostatectomy
Predictive factors for intraoperative bleeding during robot-assisted radical prostatectomy prostate cancer
Role of fibrin sealants like TachoSil reducing blood loss RARP outcomes